Last reviewed · How we verify
EDP2939
At a glance
| Generic name | EDP2939 |
|---|---|
| Sponsor | Evelo Biosciences, Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EDP2939 CI brief — competitive landscape report
- EDP2939 updates RSS · CI watch RSS
- Evelo Biosciences, Inc. portfolio CI